pharmaphorum January 25, 2022
The area of digital therapeutics is growing rapidly, and in this piece Ben Hargreaves examines why this is the case, how broadly these therapies can be applied and why investment in the area is mounting.
To demonstrate how quickly the digital therapeutics space is developing, it is easiest to state that the first such therapy was approved in 2018 and since that point the annual investment in the space has more than doubled in the intervening years. During the opening three quarters of investment in 2021, more funding was raised than in the entirety of 2020, according to Rock Health. This equated to $21.3 billion of venture funding provided to companies working on digital therapeutics, compared with $14.7 billion during...
Today's Sponsors
Today's Sponsor